Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Literature
1.
Ghosh A, Pradhan SV, Talwar OP (2010) Castleman’s disease—hyaline vascular type—clinical, cytological and histological features with review of literature. Indian J Pathol Microbiol 53:244–247CrossRefPubMed
2.
Medina EA, Fuehrer NE, Miller FR, Kinney MC, Higgins RA (2016) Dysplastic follicular dendritic cells in hyaline-vascular Castleman disease: a rare occurrence creating diagnostic difficulty. Pathol Int 66:535–539CrossRefPubMed
3.
Hwang SO, Lee TH, Bae SH et al (2013) Transformation of Castleman’s disease into follicular dendritic cell sarcoma, presening as an intra-abdominal mass. Korean J Gastroenterol 62:131–134CrossRefPubMed
Metadata
Title
Diagnostic Problems Created by Dysplastic Follicular Dendritic Cells in Castleman's Disease on a Trucut Biopsy
Authors
Thara Keloth
J. Sree Rekha
B. H. Srinivas
Debasis Gochhait
Debdatta Basu
Biju Pottakkat
Publication date
01-07-2019
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 3/2019
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-019-01102-z

Other articles of this Issue 3/2019

Indian Journal of Hematology and Blood Transfusion 3/2019 Go to the issue

Original Article

Clinical Efficacy and Safety of High-Dose Dexamethasone Plus Low-Dose Rituximab as First-Line Therapy in Newly Diagnosed Primary Immune Thrombocytopenia

Review Article

Allogeneic Hematopoietic Stem Cell Transplantation for Myeloma: Time for an Obituary or Not Just Yet!

Original Article

Multiparametric Flow Cytometry in Mixed Phenotype Acute Leukemia

Original Article

Establishing Blood Group Genotyping to Resolve ABO Discrepancies in Iran

Correspondence

Smoldering Multiple Myeloma Presenting as Immune Thrombocytopenia

Original Article

Matrix Metalloproteinase-2 Single Nucleotide Polymorphism in Egyptian Non-Hodgkin Lymphoma Patients: Correlation with Clinicopathological Characteristics and Outcome
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits